Home > Boards > US Listed > Medical - Healthcare >

Genomic Health Inc. (GHDX)

Add GHDX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 7/25/2019 8:20:19 AM - Followers: 8 - Board type: Free - Posts Today: 0

http://www.genomichealth.com/ http://finance.yahoo.com/q/ks?s=GHDX Genomic Health, Inc., a life science company, engages in the development and commercialization of genomic-based clinical diagnostic tests for cancer that enable physicians and patients to make individualized treatment decisions in the United States. The company's Oncotype DX is a clinical laboratory test, which is used for early stage breast cancer patients to predict the likelihood of cancer recurrence and the likelihood of chemotherapy benefit. It offers Oncotype DX as a clinical laboratory service, where it analyses the expression levels of 21 genes in tumor tissue samples in its laboratory and provide physicians with a quantitative gene expression profile expressed as a single quantitative Recurrence Score. The Oncotype DX report also includes measurements of quantitative gene expression for estrogen receptor (ER) and progesterone receptor (PR), which are used in the calculation of the Recurrence Score result. In addition, the company is in the early development phase to develop tests to predict the likelihood of response to the epidermal growth factor receptor inhibitor class of drugs, as well as for a product to predict the likelihood of taxane benefit in breast cancer patients. Further, it has products in various stages of development for other cancers, including colon cancer, prostate cancer, renal cell cancer, non-small cell lung cancer, and melanoma. The company has collaborative agreements with Aventis, Inc. and the Eastern Cooperative Oncology Group to investigate the ability of gene expression in FPE tissues to predict the likelihood of response to adjuvant chemotherapy, including the taxane Taxotere, in patients with early breast cancer and zero to three involved lymph nodes; and Bristol-Myers Squibb Company and ImClone Systems Incorporated to develop a genomic test to predict the likelihood of response to Erbitux in colorectal cancer. Genomic Health, Inc. was founded in 2000 and is based in Redwood City, California.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GHDX News: Moore Kuehn, PLLC Encourages Genomic Health, Inc. and Carbonite, Inc. Investors to Contact Firm 10/17/2019 10:57:00 AM
GHDX News: Statement of Changes in Beneficial Ownership (4) 10/09/2019 05:12:55 PM
GHDX News: Statement of Changes in Beneficial Ownership (4) 10/09/2019 05:12:14 PM
GHDX News: Statement of Changes in Beneficial Ownership (4) 10/09/2019 05:11:14 PM
GHDX News: Proxy Statement - Merger or Acquistion (definitive) (defm14a) 10/04/2019 05:03:36 PM
#34   News: $GHDX Genomic Health to Announce Second Quarter whytestocks 07/25/19 08:20:19 AM
#33   https://investorplace.com/2019/04/7-a-rated-healthcare-stocks-for-industry-expan JB6 04/08/19 09:24:43 AM
#32   investorplace.com/2019/04/7... JB6 04/08/19 09:17:10 AM
#31   http://investor.genomichealth.com/news-releases/news-release-details/new-long-te JB6 03/25/19 10:18:47 AM
#30   GHDX buy 69.34 stocktrademan 12/15/18 03:45:56 PM
#29   Yep :) rocknroll350 11/07/18 09:58:49 AM
#28   Today is the day! REVENUES BIG TIME! crudeoil24 11/07/18 09:54:55 AM
#27   "We continue to deliver record results in 2018, crudeoil24 11/07/18 09:53:39 AM
#26   Nice upside surge with GHDX!!!!! crudeoil24 11/07/18 09:49:28 AM
#25   Back in again with OTM calls Oct. 19 rocknroll350 08/31/18 02:29:42 PM
#24   Still going and big volume today for no rocknroll350 08/27/18 09:42:34 PM
#23   Took some Aug 17 lotto calls today... lets rocknroll350 07/11/18 05:23:13 PM
#22   RDHL has1 NDA filling & 2 phase 3 DorseyE 03/08/17 03:23:23 PM
#21   I'm here because the Baker Bros. are involved. RickKayne 12/06/14 12:42:23 AM
#20   Genomic Health Announces Presentation of New Oncotype DX® [SMART MONEY] 12/14/13 03:34:52 PM
#19   8:03AM Genomic Health announces presentation of two Oncotype mlkrborn 09/13/12 01:12:30 PM
#18   So much following! one upgrade today! mlkrborn 11/02/11 12:35:21 PM
#17   NGNM – worth a look... bpvitale 10/28/10 03:10:47 PM
#16   finally moving a little now, I wonder if dealorfx 09/13/10 05:09:39 PM
#15   more insider buying by Baker brothers this week, dealorfx 09/11/10 12:38:32 PM
#14   looks like GHDX could really break out to dealorfx 09/08/10 09:20:33 PM
#13   Increases in Holdings dealorfx 09/05/10 11:21:28 AM
#12   Looks great...thanks. I've not kept up...I know a sahd3g 09/04/10 08:21:17 AM
#11   Baker Bros Advisors Llc keeps adding to their dealorfx 09/04/10 07:36:11 AM
#10   Holding a very small position from swing trading sahd3g 09/03/10 01:46:30 PM
#9   anybody still trading this........ dealorfx 09/03/10 01:34:22 PM
#8   Back in GHDX for a swing trade...wanting more sahd3g 05/11/10 01:51:18 PM
#7   GHDX upgraded today! sahd3g 01/22/10 10:18:57 AM
#6   Added again yesterday at under $17. sahd3g 01/21/10 10:05:15 AM
#5   Genomic Health Reliant on One Drug surf1944 08/18/08 01:43:40 PM
#4   Genomic Health Announces Second Quarter 2008 Financial Results surf1944 08/18/08 01:43:16 PM
#3   Genomic Health chairman, CEO sells common shares surf1944 06/25/08 08:52:24 AM
#2   Genomic Health Announces Expansion of Oncotype DX(R) Breast surf1944 06/25/08 08:52:07 AM
#1   Genomic Health CEO sells 12,000 shares surf1944 05/21/08 11:07:11 AM